Oncology Central
  • Home
  • News
  • Insights
    • Insights
      • Opinion
      • Columnists
      • Journal articles
      • Events
      • Spotlights
      • In focus
      • Follow us on social media
    • ADVERT
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
      • Follow us on social media
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • Genetics
      • Preclinical research and trials
      • Prevention and screening
      • Therapies
      • View all
    • ADVERT
  • Multimedia
    • Multimedia
      • Videos
      • Podcasts
      • Infographics
      • Webinars
      • Follow us on social media
    • ADVERT
  • Register
  • i
  • i
  • i
  • Home
  • News
  • Insights
    • Opinion
    • Columnists
    • Journal articles
    • Spotlights
    • In Focus
    • Events
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • View all
  • Multimedia
    • Videos
    • Infographics
    • Podcasts
    • Webinars
  • Registration
  • Follow us on social media
  • i
  • i

Login

Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.

Forgot your password?

Or register via social media

Already have an account? Login here

Or register via social media

Already have an account? Login here

Most searched
  • ask the experts
  • aacr
  • asco
  • IMpower150
  • research

CAR-T cells

  • 29 Aug 2018 CAR-T therapy

    CAR-T therapy Yescarta get EU green light but meets resistance from NICE

  • 15 May 2018 CAR-T therapy

    Scientific and regulatory challenges in development of CAR-T therapy for solid tumors

  • 11 Dec 2017 CAR-T therapy

    International CAR-T therapy trial yields high rates of durable remission for non-Hodgkin’s lymphoma

  • 1 Sep 2017 News

    Clinical trial reports first response of central nervous system tumor to CAR T-cells

  • 8 Dec 2016

    CAR T-cell immunotherapy results in high response rates in treatment-resistant CLL

  • 15 Sep 2016

    Promising results demonstrated for CAR-T therapy in advanced non-Hodgkin lymphoma patients

  • About us
  • Contact Us
  • Our journals
  • Advertising & Sponsorship
  • Ambassadors
  • Twitter
  • Facebook
  • Linkedin
  • RSS
  • Oncology Central Newsletter

    Like our content? Subscribe to our weekly newsletter for news & articles direct to your inbox.


    Stay connected
    • Twitter
    • Facebook
    • Linkedin
    • RSS
  • Find a job

    Connecting talent with opportunity, have a look at our Career Center and find your ideal next career move.

    Registration

    When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

    Office Info

    Oncology Central is powered by Future Science Group.
    Unitec House, 2 Albert Place, London, N3 1QB, UK,
    +44 (0)20 8371 6090

    • About us
    • Contact Us
    • Our journals
    • Advertising & Sponsorship
    • Ambassadors
    • Find a job

      Connecting talent with opportunity, have a look at our Career Center and find your ideal next career move.

      Registration

      When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

      Office Info

      Oncology Central is powered by Future Science Group.
      Unitec House, 2 Albert Place, London, N3 1QB, UK,
      +44 (0)20 8371 6090

  • Future Science Group
  • Cookies Policy
  • Privacy Policy
  • Terms & Conditions
  • ©2019 Oncology Central
© 2018 Oncology Central